...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: plenty of scenarios being put out there...

"....Furthermore, Fundamentals6 on the InvestorVillage board made a good post yesterday suggesting that we vote against this resolution unless we get more information from Zenith regarding what their plans are here...."

I'm inclined to vote against it as well. However, there is a section titled "Dissent Rights" starting on page 8 of the Management Information Circular (Dec 2, SEDAR) that folks might want to read first.

Share
New Message
Please login to post a reply